Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(ranibizumab)
4,353 results
  • [Central venous occlusion in Wyburn-Mason syndrome]. [Journal Article]
  • OOphthalmologe 2019 Jun 17
  • Toepffer AM, Wecke T, … Thieme H
  • The diagnostic findings, therapy and course of disease are described for a case of central venous occlusion in Wyburn-Mason-Syndrome. The diagnosis was based on OCT, fluorescein angiography and cMRI.…
  • Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema. [Journal Article]
  • BOBMJ Open Ophthalmol 2019; 4(1):e000226
  • Chakravarthy U, Pearce I, … Lupton S
  • CONCLUSIONS: Although ranibizumab treatment in DMO over an 18-month period resulted in improvements in visual functioning and patient satisfaction, no correlation was found between the instruments used to measure these outcomes. Our finding of a lack of correlation between BCVA and the MacTSQ suggests the presence of psychophysical factors not measured by traditional means.
New Search Next